Ligand Pharmaceuticals
LGND
#4056
Rank
NZ$3.97 B
Marketcap
$210.15
Share price
-1.10%
Change (1 day)
78.72%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.73. In 2022 the company made an earnings per share (EPS) of -$3.45 a decrease over its 2021 EPS that were of $6.03.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-173.51%
2022-$3.45-157.23%
2021$6.03-2571.43%
2020-$0.24-100.46%
2019$53.31353.48%
2018$11.761025%
2017$1.04-700%
2016-$0.17-100.87%
2015$20.131859.32%
2014$1.035.36%
2013$0.988.0704505322479E+18%
2012$0.0000000000-100%
2011$0.85-194.23%
2010-$0.91548.38%
2009-$0.14-98.7%
2008-$10.76-136.52%
2007$29.47-787.8%
2006-$4.28-14.58%
2005-$5.02-21.31%
2004-$6.37-55.15%
2003-$14.2181.33%
2002-$7.842.74%
2001-$7.63-45.93%
2000-$14.11-14.56%
1999-$16.51-45.52%
1998-$30.30-3.97%
1997-$31.56132.31%
1996-$13.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.64 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.63-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.10 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.17 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.24 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.46 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.91 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.92 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.53 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA